Jerrold H. Levy , Peta M. A. Alexander , Alisa S. Wolberg , Owen J. T. McCarty , Anthony E. Pusateri , Raquel R. Bartz , Wolfgang Bergmeier , Mitchell J. Cohen , Jean M. Connors , James H. Morrissey , Matthew D. Neal , Elisabeth T. Tracy , Keith McCrae , Bruce A. Sullenger
{"title":"ecmo诱导的凝血病：研究和临床实践的战略举措（NHLBI研讨会报告）","authors":"Jerrold H. Levy , Peta M. A. Alexander , Alisa S. Wolberg , Owen J. T. McCarty , Anthony E. Pusateri , Raquel R. Bartz , Wolfgang Bergmeier , Mitchell J. Cohen , Jean M. Connors , James H. Morrissey , Matthew D. Neal , Elisabeth T. Tracy , Keith McCrae , Bruce A. Sullenger","doi":"10.1016/j.bvth.2025.100064","DOIUrl":null,"url":null,"abstract":"<div><h3>Abstract</h3><div>In May 2024, the Division of Blood Diseases and Resources of the National Heart, Lung, and Blood Institute (NHLBI) hosted a hybrid workshop on “Extracorporeal membrane oxygenation (ECMO)-induced coagulopathy: strategic initiatives for research and clinical practice.” The event brought together clinicians, scientists, bioengineers, and policymakers to address the challenges of ECMO-associated coagulopathy and explore novel therapeutic approaches. Through expert presentations and collaborative discussions, the workshop focused on innovative anticoagulation strategies, precision medicine, and advanced diagnostics to enhance patient care. The discussions also identified critical research gaps and opportunities for future interdisciplinary collaboration. This summary reviews the current state of knowledge and outlines future research directions for improving ECMO-induced coagulopathy management.</div></div>","PeriodicalId":100190,"journal":{"name":"Blood Vessels, Thrombosis & Hemostasis","volume":"2 2","pages":"Article 100064"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"ECMO-induced coagulopathy: strategic initiatives for research and clinical practice (a workshop report of the NHLBI)\",\"authors\":\"Jerrold H. Levy , Peta M. A. Alexander , Alisa S. Wolberg , Owen J. T. McCarty , Anthony E. Pusateri , Raquel R. Bartz , Wolfgang Bergmeier , Mitchell J. Cohen , Jean M. Connors , James H. Morrissey , Matthew D. Neal , Elisabeth T. Tracy , Keith McCrae , Bruce A. Sullenger\",\"doi\":\"10.1016/j.bvth.2025.100064\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Abstract</h3><div>In May 2024, the Division of Blood Diseases and Resources of the National Heart, Lung, and Blood Institute (NHLBI) hosted a hybrid workshop on “Extracorporeal membrane oxygenation (ECMO)-induced coagulopathy: strategic initiatives for research and clinical practice.” The event brought together clinicians, scientists, bioengineers, and policymakers to address the challenges of ECMO-associated coagulopathy and explore novel therapeutic approaches. Through expert presentations and collaborative discussions, the workshop focused on innovative anticoagulation strategies, precision medicine, and advanced diagnostics to enhance patient care. The discussions also identified critical research gaps and opportunities for future interdisciplinary collaboration. This summary reviews the current state of knowledge and outlines future research directions for improving ECMO-induced coagulopathy management.</div></div>\",\"PeriodicalId\":100190,\"journal\":{\"name\":\"Blood Vessels, Thrombosis & Hemostasis\",\"volume\":\"2 2\",\"pages\":\"Article 100064\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Blood Vessels, Thrombosis & Hemostasis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S295032722500021X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Vessels, Thrombosis & Hemostasis","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S295032722500021X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
ECMO-induced coagulopathy: strategic initiatives for research and clinical practice (a workshop report of the NHLBI)
Abstract
In May 2024, the Division of Blood Diseases and Resources of the National Heart, Lung, and Blood Institute (NHLBI) hosted a hybrid workshop on “Extracorporeal membrane oxygenation (ECMO)-induced coagulopathy: strategic initiatives for research and clinical practice.” The event brought together clinicians, scientists, bioengineers, and policymakers to address the challenges of ECMO-associated coagulopathy and explore novel therapeutic approaches. Through expert presentations and collaborative discussions, the workshop focused on innovative anticoagulation strategies, precision medicine, and advanced diagnostics to enhance patient care. The discussions also identified critical research gaps and opportunities for future interdisciplinary collaboration. This summary reviews the current state of knowledge and outlines future research directions for improving ECMO-induced coagulopathy management.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
